Optimizing Asthma Care In The Elderly: A Guidelines-Based Therapeutic Approach For Enhanced Diagnosis And Management

Asthma is a chronic inflammatory disease that predominantly affects the airways, leading to symptoms such as wheezing, breathlessness, and chest tightness. In elderly patients, who constitute approximately 7-10% of asthma cases, the condition presents unique challenges due to age-related physiological changes, comorbidities, and pharmacological sensitivities. Diagnosing asthma in this population is often complicated by the overlap of symptoms with other respiratory conditions like Chronic Obstructive Pulmonary Disease (COPD), further exacerbated by smoking history and cognitive decline. Pulmonary function tests, especially spirometry and bronchodilator reversibility tests, are essential but underutilized in this demographic, leading to under-diagnosis and suboptimal management. Management of asthma in the elderly requires a tailored approach, guided by well-established protocols such as those from the Global Initiative for Asthma (GINA) and the National Asthma Education and Prevention Program (NAEPP). These guidelines advocate the use of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABAs) as cornerstones of therapy, with adjustments for physiological and pharmacokinetic changes in older adults. Non-pharmacological interventions, including lifestyle modifications and vaccination, also play a crucial role in preventing exacerbations. However, the increased risk of adverse drug reactions and polypharmacy further complicates treatment, requiring personalized care to mitigate risks. This review emphasizes the importance of adhering to guideline-based therapeutic strategies and highlights the need for further research focused on age-specific clinical trials and biologic therapies tailored to the elderly. By addressing the complexities of asthma in elderly patients, healthcare providers can enhance disease management and improve the quality of life for this vulnerable population.